Renal Transplantation: A Perspective on Recent Advances and Controversies
1993; Wiley; Volume: 6; Issue: 1 Linguagem: Inglês
10.1111/j.1525-139x.1993.tb00247.x
ISSN1525-139X
Autores Tópico(s)Organ Transplantation Techniques and Outcomes
ResumoSeminars in DialysisVolume 6, Issue 1 p. 20-25 Renal Transplantation: A Perspective on Recent Advances and Controversies Margaret J. Bia, Corresponding Author Margaret J. Bia Yale University School of Medicine, Department of Medicine, New Haven, ConnecticutAddress correspondence to: Margaret J. Bia, MD, Professor of Medicine, Director, Transplant Nephrology, Renal Section, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510.Search for more papers by this author Margaret J. Bia, Corresponding Author Margaret J. Bia Yale University School of Medicine, Department of Medicine, New Haven, ConnecticutAddress correspondence to: Margaret J. Bia, MD, Professor of Medicine, Director, Transplant Nephrology, Renal Section, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510.Search for more papers by this author First published: January 1993 https://doi.org/10.1111/j.1525-139X.1993.tb00247.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 National Organ Procurement and Transplantation Network: 1991 Transplant Statistics. Unos Update 8: 2, 1992. 2 US Renal Data System: USRDS 1991 Annual Data Report. Bethesda , MD , The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, August 1991. 3 Groth CG, Lindholm A, Ohlman S: Strategies for immunosuppression in kidney transplantation—selected topics. Clin Transplant 5: 540–543, 1991. 4 Ponticelli C, Tarantino A, Montagnino G, et al.: A randomized trial comparing triple-drug and double-drug therapy in renal transplantation. Transplantation 45: 913–917, 1988. 5 Schroeder TJ, First RM, Monsour ME, et al.: Prophylactic use of OKT3 in immunologic high risk cadaveric renal transplant patients. Am J Kidney Dis 14: 14–18, 1989. 6 Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al.: Increased incidence of lymphoproliferative disorders after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 323: 1723–1728, 1990. 7 Rubin RT, Tolkoff-Rubin NE: Infection: The new problems. Transplant Proc 21: 1440–1445, 1989. 8 Kahan BD: Cyclosporine nephrotoxicity: Pathogenesis, phrophylaxis, therapy and prognosis. Am J Kidney Dis 8: 323–331, 1986. 9 Hricik D, Lautman J, Bartucci MR, et al.: Variable effects of steroid withdrawal on blood pressure reducion in cyclosporine treated renal transplant recipients. Transplantation 53: 1232–1235, 1992. 10 Vollmer W, Wahl PW, Blagg CR: Survival with dialysis and transplantation in patients with end stage renal disease. N Engl J Med 308: 1553–1558, 1983. 11 The Canadian Multicenter Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 314: 1219–1225, 1986. 12 Amend W, Soskin T, Vincenti F, et al.: Long term experience in primary cadaver renal transplants using cyclosporine. Clin Transplant 4: 341–346, 1990. 13 Johnson JP, McCauley CR, Copley JB: The quality of life of hemodialysis and transplant patients. Kidney Int 22: 286–291, 1982. 14 Evans R, Mannenen DL, Garrison LP: The quality of life of patients with end stage renal disease. N Engl J Med 312: 553–559, 1985. 15 The Medicare End-Stage Renal Disease Program: A report from the Institute of Medicine. N Engl J Med 324: 1143–1148, 1991. 16 Kramer N, Peters T, Rohr M, et al.: Beneficial effect of cyclosporine on renal transplantation. Transplantation 49: 343–348, 1990. 17 Eggers P: Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 318: 223–229, 1988. 18 Sumrani N, Delaney V, ZhongKun D, et al.: HLA identical renal transplants: Impact of cyclosporine an intermediate term survival and renal function. Am J Kidney Dis 14: 417–422, 1990. 19 Monaco AP, Sahyoun AI, Madras PN, et al.: Cyclosporine in multidrug therapy in living related kidney transplant. Clin Transplant 4: 347–356, 1990. 20 Sommer BG, Bowers VD, Henry ML, et al.: Mismatched living related donor transplantation: Donor-specific transfusions vs cyclosporine. Clin Transplant 2: 36–41, 1988. 21 Fabrega A, Matas AJ, Payne WD, et al.: Ten to 20 year follow-up of 123 consecutive HLA-identical living-related kidney transplants from the pre-cyclosporine era. Clin Transplant 4: 142–152, 1990. 22 Terasaki P, Mickey MR, Iwak Y: Long term survival of kidney grafts. Transplant Proc 21: 615–617, 1989. 23 Myers BD, Ross J, Newton L, et al.: Cyclosporine-associated chronic nephropathy. N Engl J Med 311: 699–704, 1984. 24 Nast CC, Adler SG, Artishevsky A, et al.: Cyclosporine induces elevated procollagen alpha 1 (I)m RNA levels in the rat renal cortex. Kidney Int 39: 631–638, 1991. 25 Almond PS, Gillingham KJ, Sibley R, et al.: Renal transplant function after ten years of cyclosporine. Transplantation 53: 316–323, 1992. 26 Lewis R, Van Buren CT, Kerman RH, et al.: A review of long term cyclosporine use in renal transplantation. Clin Transplant 4: 312–320, 1990. 27 Braun W: Long term complications of renal transplantation. Kidney Int 37: 1363–1378, 1990. 28 Hill MN, Grossman RA, Feldman HI: Changes in causes of death after renal transplantation. Am J Kidney Dis 17: 512–518, 1991. 29 Higgins RM, Ratcliffe PJ: Hypercholesterolemia and vascular disease after renal transplantation. Transplant Rev 5: 131–149, 1991. 30 Yoshimura N, Nakai I, Ohmori Y, et al.: Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant patients. Am J Kidney Dis 12: 11–17, 1988. 31 Penn I, Brunsen ME: Cancer after cyclosporine therapy. Transplant Proc 22 (Suppl 3): 885–892, 1988. 32 Colon EA, Popkin MK, Matas AJ, et al.: Overview of non-compliance in renal transplantation. Transplant Rev 5: 175–180, 1991. 33 Matas AJ: Long-term kidney transplant outcome. Contemp Dial Nephrol August: 18–21, 1991. 34 Khauli RB, Steinmuller DR, Novick AC, et al.: A critical look at survival of diabetics with end stage renal disease. Transplantation 41: 598–602, 1986. 35 Khauli RB, Novick AC, Steinmuller DR, et al.: Patient survival and rehabilitation of diabetes with end stage renal disease: Comparison of therapeutic modalities. Transplant Proc 17: 178–181, 1985. 36 Solders G, Wilczek H, Gunnarsson R, et al.: Effects of combined pancreas and renal transplantation on diabetic neuropathy. A two-year follow-up study. Lancet 2: 1232–1235, 1987. 37 Barker RJ, Mayes JT, Schulak JA: Wound abscess following retioperitoneal pancreas transplantation. Clin Transplant 5: 403–407, 1991. 38 Sutherland DER: Immunosuppression for clinical pancreas transplantation. Clin Transplant 5: 549–553, 1991. 39 Moudry-Munns KC, Gillingham K, Sutherland DER: Pancreas registry report: Clinical pancreas transplantation. J Transplant Coord 1: 11–14, 1991. 40 Schulak JA, Mayes JT, Hricik DE: Kidney transplantation in diabetic patients undergoing combined kidney-pancreas or kidney-only transplantation. Transplantation 53: 685–687, 1992. 41 Bilous RW, Mauer SM, Sutherland DER, et al.: The effects of pancreas transplantation in the glomerular structure of renal allografts in patients with insulin dependent diabetes. N Engl J Med 321: 80–85, 1989. 42 Hunsicker LG: Renal transplantation for the nephrologist: Is pancreas transplantation for diabetic ESRD now accepted therapy Am J Kidney Dis 15: 93–96, 1990. 43 Kasiski BL, Neylan JF, Riggio RR, et al.: The effect of race in access and in transplantation. N Engl J Med 324: 302–307, 1991. 44 Collander CO, Hall LE, Yeager CL: Organ donation and blacks. N Engl J Med 325: 442–444, 1991. 45 Kusserow RP: The Distribution of Organs for Transplantation: Expectations and Practices, Publication OEI-01–89–00550. Washington , DC , Office of the Inspector General, Office of Evaluations and Inspections, 1990, pp. 1–12. 46 Bauer MP, Danilous JA. Population analysis of HLA A, B, C, DR and other genetic markers, in Histocompatibility Testing 1980, edited by PI. Terasaki Los Angeles , UCLA Typing Laboratory, 1980, pp. 993–995. 47 Hurley CK: Reducing transplant rejection in blacks. Dial Transplant 20: 510–515, 1991. 48 Weller JM, Wu SC, Fergusen CW, et al.: Influence of race of cadaveric kidney donor and recipient in graft survival: A multifactorial analysis. Am J Kidney Dis 9: 191–199, 1987. 49 Terasaki P, Takemoto S, Mickey MR: A report on 123 six antigen matured cadaveric kidney transplants. Clin Transplant 3: 301–305, 1989. 50 Kerman R, Kimball PM, Van Buren CT, et al.: Stronger immune responsiveness of blacks vs whites may account for renal allograft survival differences. Transplant Proc 23: 380, 1991. 51 Shah B, First R, Munda R: Current experience with renal transplantation in older patients. Am J Kidney Dis 12: 516–523, 1988. 52 Schulak J, Mayes JT, Johnston KH, et al.: Kidney transplantation in patients aged 60 years and older. Surgery 108: 726–733, 1990. 53 Weigle WO: Effects of aging on the immune system. Hosp Pract 112–119, 1989. 54 Kjellstrand C: The distribution of renal transplants—Are physicians just Transplant Proc 22: 964–965, 1990. 55 National Organ Procurement and Transplantation Network: Transplantations waiting for cadaveric organs. Unos Update 7: 14, 1991. 56 Spital A: The shortage of organs for transplantation. Where do we go from here N Engl J Med 325: 1243–1246, 1991. 57 Randall T: Too few human organs for transplantation, too many in need… and the gap widens. JAMA 265: 1223–1227, 1991. 58 Garrison RN, Bentley FR, Rague GH, et al.: There is an answer to the shortage of organ donors. Surg-Gynecol Obstet 173: 391–396, 1991. 59 Pirsch JD, Sollinger HW, Kalayoglu M: Living unrelated renal transplantation: Results in 40 patients. Am J Kidney Dis 12: 499–503, 1988. 60 Kaufman DM, Matas AJ, Najarian JS: Expanding the pool of living donors: Transplantation of kidneys from zero haplotype matched donors and distantly related and unrelated donors. Proc 11th Annu Meet Am Soc Transplant Phys 129, 1992. 61 Posselt AM, Barker CF, Tomaszewski JE, et al.: Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 241: 1293–1295, 1990. 62 Perico N, Rossini M, Imberti O, et al.: Thymus-mediated immune tolerance to renal allograft is donor but not tissue specific. J Am Soc Nephrol 2: 1063–1071, 1991. 63 Van Twuyver E, Mooijaart RJD, Ten Berge TJM, et al.: Pretransplant blood transfusion revisited. N Engl J Med 325: 1210–1213, 1991. Citing Literature Volume6, Issue1January 1993Pages 20-25 ReferencesRelatedInformation
Referência(s)